Lonza Potelligent CHOK1SV host cell line
Potelligent CHOK1SV, a host cell line for manufacturing recombinant antibodies, combines BioWa’s glycosylation Potelligent technology with Lonza’s GS Gene Expression System and CHOK1SV.
The cell line retains the features of a high-productivity cell line (robust, high-yielding, scalable) and the bioprocess platform for CHOK1SV is repeatable in the new cell line.
Antibodies produced by the new cell line: exhibit enhanced antibody dependent cellular cytotoxicity (ADCC) even with the low-ADCC allotype of CD16, overcoming CD16 polymorphism; can exert potent cytotoxic effects when their target antigen is low; work in whole blood; and retain required features of antibodies, such as Protein A binding.
Phone: 1300 657508
Selleck Chemicals FDA-approved Anticancer Drug Library
Selleck Chemicals (SelleckChem) offers a collection of 1734 approved drugs with potential...
Cytek Tonbo Mouse TBNK/Myeloid/Treg Kit
The kit has been designed to enable researchers to quickly perform basic immunophenotyping and...
FUJIFILM Irvine Scientific Shenandoah Cytokines
FUJIFILM Irvine Scientific provides recombinant cytokines to the academic and industrial...
